Global Organ Transplantation Market, By Product Type (Organ Preservation Products, Transplant Diagnostics, Immunosuppressant Drugs, Tissue Products, Other), Application (Kidney, Liver, Heart, Pancreas, Others), Type of Transplant (Autograft, Allograft, Others), Treatment (Analgesic, Immunosuppressant, Others), End User (Hospitals, Transplant Centers, Others) – Industry Trends and Forecast to 2029.
Organ Transplantation Market Analysis and Size
The organ transplantation market is growing largely across the globe and is expected to grow at the same pace within the forecast period. Increased social awareness regarding the organ transplantation is estimated to accelerate the market's growth.
- Data Bridge Market Research analyses that the organ transplantation market is expected to grow at a CAGR of 9.36% during the forecast period. The "kidney" accounts for the largest application segment in the organ transplantation market within the forecasted period.
Organ Transplantation Market Definition
The organ transplantation market basically deals with the transplantation procedure of the organs. Organ transplantation is a medical procedure in which an organ is removed from one body and transplanted into another to fill a gap or replace a damaged or missing organ. This procedure is mostly used to treat organ failure in the lungs, kidneys, liver, and other organs. Patients with a dead brain whose other organs are healthy and can be used to save another person's life are the most common candidates for organ transplantation. Prior to this dynamic procedure, the family's or the patient's consent is critical, as organ harvesting is an illegal and heinous crime without consent.
Organ Transplantation Market Dynamics
Growing Organ Failures and Organ Donations Procedure
The increasing amount of the chronic disease which result in organ failures is the most significant factor driving the growth for this market. Growing organ donation across the globe also results in influencing people towards the organ transplantation procedure which is expected to accelerate the overall growth of the market. Moreover, the overconsumption of alcohol and unhealthy diet being prevalent among the population, resulting in organ failure accelerate the market's growth.
The spread of personal insurance along with the lifestyle factors adding to the burden of illness are projected to cushion he growth of the market. Moreover, organ and tissue procurement and its preservation is also expected to fuel market growth. Moreover, the rising disposable income and increased globalization and skills transfer within the medical community also cushions the market's growth within the forecasted period.
Furthermore, the advances in the technology and development within the medical sector such as the developing techniques for vascular anastomoses, managing the immune response (chemical immunosuppressants) and devising preservation solutions are projected to extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Moreover, the progress in medical biotechnology will further expand the organ transplantation market's growth rate in the future.
On the other hand, the high cost of this transplantation procedure as the transplantation is very complex procedure and it requires excellent skills to perform it and there is a very less number of surgeons present in this field who can perform these types of procedures which is expected to obstruct market growth. Also, the sprouting crises of organ demand and shortage of organ donors are projected to challenge the organ transplantation market in the forecast period of 2022-2029.
This organ transplantation market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the organ transplantation market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Organ Transplantation Market
The healthcare industry has been largely impacted by the COVID-19. However, the organ transplantation market was negatively affected by the sudden outbreak of the COVID-19 pandemic due to the government's various strict guidelines and regulations regarding social distancing and movement restrictions, which resulted in the negative impact on various operations such as the manufacturing, developing, production, and logistic units. The number of transplant procedures was also limited, as it was recently discovered in studies that post-transplantation patients were at a higher risk of contracting Covid-19 infection.
- In November 2020, LUPIN announced the launch of TACROLIMUS, a generic immunosuppressant drug indicated for the prevention of organ rejection in allogeneic liver, kidney, and heart transplants, in the US market.
Global Organ Transplantation Market Scope
The organ transplantation market is segmented on the basis of product type, application, type of transplant, treatment and end user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
- Organ Preservation Products
- Transplant Diagnostics
- Immunosuppressant Drugs
- Tissue Products
On the basis of product type, the organ transplantation market is bifurcated into organ preservation products, transplant diagnostics, immunosuppressant drugs, tissue products, and other. The immunosuppressant drugs is further sub-segmented into CALCINEURIN inhibitors, mTOR inhibitors, anti-proliferative agents, steroids, and others. CALCINEURIN inhibitors are further divided into TACROLIMUS and cyclosporine. And MTOR is further divided into SIROLIMUS and EVEROLIMUS.
On the basis of application, the organ transplantation market is segmented into kidney, liver, heart, pancreas, and others. Kidney is expected to show a significant growth within the forecasted period as it is the most donated organ amongst the other organs.
Type of Transplant
On the basis of type of transplant, the organ transplantation market is divided into autograft, allograft, and others.
On the basis of treatment, the organ transplantation market is fragmented into analgesic, immunosuppressant, and others.
- Transplant Centers
On the basis of end user, the organ transplantation market is segregated into hospitals, transplant centres and others.
Organ Transplantation Market Regional Analysis/Insights
The organ transplantation market is analyzed and market size insights and trends are provided by country, product type, application, type of transplant, treatment and end user as referenced above.
The countries covered in the organ transplantation market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the organ transplantation market because of the high prevalence of organ failures of patients, presence of established healthcare infrastructure and advanced transplant centers in the U.S and consistent development of healthcare infrastructure within the region. Asia-Pacific is expected to witness significant growth during the forecast period of 2022 to 2029 due to the high prevalence of organ failures of patients, and consistent development of healthcare infrastructure in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure Growth Installed Base and New Technology Penetration
The organ transplantation market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for organ transplantation market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the organ transplantation market. The data is available for historic period 2010-2020.
Competitive Landscape and Organ Transplantation Market Share Analysis
The organ transplantation market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to organ transplantation market.
Some of the major players operating in the organ transplantation market are Medtronic, Novartis AG, Pfizer Inc., Sanofi, Terumo Corporation, Preservation Solutions, Inc., TransMedics, Inc., Organ Recovery System, Transonic, AbbVie Inc., Stryker, Zimmer Biomet, 21st Century Medicine, BioLife Solutions ., Teva Pharmaceutical Industries Ltd., Veloxis Pharmaceuticals Inc, Redhill Biopharma Ltd., Organdonor, and NHS Blood and Transplant among others.